January 6th, 20201KENILWORTH, NJ — A new drug, Lynparza (olaparib) has been approved for pancreatic cancer patients in the United States whose disease has not progressed on at least 16 weeks of a 1st-line platinum-based chemotherapy regimen, a report from Fox 2 Detroit said.
The drug, which was originally created for ovarian cancer sufferers, was...
